Priority Date: 27.01.12 (JP 20120015982)

NOVEL ANTITUMOR AGENT AND METHOD FOR SCREENING SAME

  • Application ID: EP13740969
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

operating since 1998
Headquarter in Sint-Martens-Latem and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61, C12, and G01 De Clercq & Partners cvba is specialized in the combination A61, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Kilburn & Strode LLP and 75 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 27.01.2012 - Priority Date (JP 20120015982)
  • 01.08.2013 - Publication A1 (WO2013111897)
  • 10.12.2014 - Publication A1 (EP2810655)